
Opinion|Videos|April 28, 2025
Clinical Benefits of BPH Treatments
Author(s)Christopher E. Kelly, MD
Panelist discusses how clinical data from multiple studies demonstrate that aqua ablation therapy offers efficacy comparable with that of transurethral resection of the prostate (TURP) while providing superior safety, functionality, and durability benefits.
Advertisement
Episodes in this series

Video content above is prompted by the following:
Aqua Ablation Therapy Benefits
Efficacy:
- Aqua ablation demonstrates noninferior, equal, or superior results compared with TURP (gold standard).
- Measured by International Prostate Symptom Score and Qmax (flow rate).
- 5-year data confirm strong symptom improvement comparable with TURP.
Safety:
- Urinary incontinence:0.1% (aqua ablation) vs up to 7%+ (TURP)
- Blood transfusion rate:0.1% (aqua ablation), lower than TURP
- Ejaculation preservation:89%-90% (aqua ablation) vs ~75% (TURP)
- Erectile dysfunction rate:0% for aqua ablation
Durability:
- Retreatment rate (5 years):
- TURP: ~12%
- Aqua ablation: ~6% (half of TURP’s rate)
Aqua ablation provides a safer, more durable alternative to TURP with comparable or superior efficacy.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
2
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
3
FDA approves zoliflodacin for uncomplicated urogenital gonorrhea
4
FDA approves first-line Zenflow system for the treatment of BPH
5

















